These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7842272

  • 1. Hypertensive cardiovascular disease and the treatment of hypertension in the elderly.
    Pearce KA, Furberg CD.
    Curr Opin Nephrol Hypertens; 1994 Mar; 3(2):213-7. PubMed ID: 7842272
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reducing the risk for coronary heart disease and stroke in hypertensives--comments on mechanisms for coronary protection and quality of life.
    Wikstrand J.
    J Clin Pharm Ther; 1992 Feb; 17(1):9-29. PubMed ID: 1548319
    [Abstract] [Full Text] [Related]

  • 7. Controlled clinical trials of drug treatment for hypertension. A review.
    Cutler JA, MacMahon SW, Furberg CD.
    Hypertension; 1989 May; 13(5 Suppl):I36-44. PubMed ID: 2490827
    [Abstract] [Full Text] [Related]

  • 8. Experiences from hypertension trials--effects on stroke and coronary heart disease.
    Berglund G.
    Drugs; 1988 May; 36 Suppl 3():5-8. PubMed ID: 3076121
    [Abstract] [Full Text] [Related]

  • 9. Office management of hypertension in older persons.
    Aronow WS.
    Am J Med; 2011 Jun; 124(6):498-500. PubMed ID: 21605724
    [Abstract] [Full Text] [Related]

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Jun; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Managing the elderly hypertensive patient beyond blood pressure reduction.
    Holzgreve H.
    J Hypertens Suppl; 1995 Aug; 13(2):S103-7. PubMed ID: 8576779
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.
    Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH.
    Lancet; 1990 Apr 07; 335(8693):827-38. PubMed ID: 1969567
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.
    Messerli FH, Grossman E, Goldbourt U.
    JAMA; 1998 Jun 17; 279(23):1903-7. PubMed ID: 9634263
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS.
    JAMA; 2003 May 21; 289(19):2534-44. PubMed ID: 12759325
    [Abstract] [Full Text] [Related]

  • 20. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM.
    Adv Exp Med Biol; 2017 May 21; 956():149-166. PubMed ID: 27957711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.